Sign up to receive the UM Ventures e-newsletter, new technology announcements, and other news.
OmniSpeech is an innovative software technology company that aims to revolutionize the
A University of Maryland College Park spin-out, is developing a non-invasive method to
Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical
N5 Sensors, Inc. of Rockville, MD is a University of Maryland spin-off leveraging
Gliknik is a privately held biopharmaceutical company working to ease human suffering by
Remedy Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on the
Blnk has created a wireless, bedside monitor, delivering live, up to the minute, trended
A medical device start-up which operates with a vision of user-directed advancement in
Engineers from the University of Maryland’s Chemical Engineering Department teamed up
UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.